Sai Life Sciences Limited has revised its intimation regarding the allotment of equity shares under its Employee Stock Option Plans (ESOP). The company had inadvertently carried out the initial allotment and has requested that it be disregarded. The revised details pertain to the allotment of equity shares under the Management Employees Stock Option Plan 2018 (MESOP 2018) and ESOP Plan 2008.
The Board of Directors, in a meeting held on September 3, 2025, approved and allotted 150,000 fully paid-up equity shares of Re.1 each under MESOP 2018, and 500 fully paid-up equity shares of Re.1 each under ESOP 2008.
The details of the allotment are provided in Annexure-A (MESOP 2018) and Annexure-C (ESOP 2008), as per Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Further details as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure-B (MESOP 2018) and Annexure-D (ESOP 2008).
Details of Allotment under MESOP 2018 (Annexure-A):
Details of Allotment under ESOP 2008 (Annexure-C):
Key Highlights from Annexure-B (MESOP 2018):
Key Highlights from Annexure-D (ESOP 2008):
The objective of both MESOP 2018 and ESOP 2008 is to incentivize, attract, retain, and reward employees, contributing to the company's growth. The vesting and exercise periods are defined as per the respective plan clauses.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.